Precise Pathogen Detection and Clinical Characterization of Bronchiectasis

Researchers from Kunming, People's Republic of China, have detailed new data in Lung Diseases and Conditions - Bronchiectasis. The study collected and analyzed clinical data and lower respiratory tract pathogen detection results from 410 patients with bronchiectasis admitted to the Anning First People's Hospital Affiliated to Kunming University of Science and Technology between August 2020 and August 2024. The aim of the study was to evaluate the utility of molecular diagnostic techniques in identifying pathogens in bronchiectasis and investigate the differences in clinical characteristics and pathogen distribution among patients with different microbial infections.

Key Takeaways:

• The study demonstrated that molecular diagnostics showed significantly higher sensitivity, positive predictive value, and negative predictive value compared to conventional microbiological testing (CMT).
• The most frequently detected bacteria were Escherichia coli (26.83%), Pseudomonas aeruginosa (14.88%), Staphylococcus aureus (13.17%), Haemophilus influenzae (9.02%), and Klebsiella pneumoniae (4.39%).
• Patients infected with Pseudomonas aeruginosa had significantly lower body mass index (BMI) compared to those infected with Escherichia coli, as well as more severe lung function impairment.
• Inflammatory markers, including white blood cell (WBC) count and C-reactive protein (CRP), were significantly higher in the group infected with Pseudomonas aeruginosa than in the group infected with Escherichia coli.
• The application of molecular diagnostic technology has significantly improved the detection rate of pathogens in patients with bronchiectasis, especially for fastidious bacteria and rare pathogens.

Statistics:

• 410 patients with bronchiectasis were included in the study.
• The study collected and analyzed clinical data and lower respiratory tract pathogen detection results from 410 patients with bronchiectasis.
• Molecular diagnostics showed a true-positive rate of 95.6% in patients infected with Pseudomonas aeruginosa and 92.1% in patients infected with Escherichia coli.
• The false-negative rate of culture was markedly higher in patients infected with Pseudomonas aeruginosa (23.5%) compared to those infected with Escherichia coli (10.3%).

Sources:

• Precise pathogen detection and clinical characterization of bronchiectasis. Frontiers in Cellular and Infection Microbiology, 2025;15:1670925.
• Findings from Jiahao Xu and Co-Authors Provide New Insights into Bronchiectasis (Precise pathogen detection and clinical characterization of bronchiectasis). Respiratory Therapeutics Week. October 27, 2025; p 1067.